RXRX - Jim Cramer Offers His Take On Corning Calls This Healthcare Stock A 'Terrific Spec' | Benzinga
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a “terrific spec” and he recommended buying the same.
On May 9, Recursion Pharmaceuticals reported better-than-expected first-quarter financial results.
Corning Incorporated (NYSE:GLW) has “not been able to generate the kind of return that I've wanted,” Cramer said. “I would not be a buyer all the way up here.”
See Also: Jim Cramer Says This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir
On May 7, Mizuho analyst John Roberts initiated coverage on Corning with a ...